Avantor schedules October 28 results. TD Cowen targets Avantor stock at USD 17.00
Published on 10/24/2026 at 20:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSResults date and analyst targets
- Avantor scheduled third-quarter results for October 28, 2026, while TD Cowen set a USD 17.00 target on October 13, 2026.
- Second-quarter 2026 revenue reached USD 1.69 billion, up 0.50 percent year over year.
- Avantor stock last traded at USD 17.29 on October 23, 2026 at 4:00 p.m. ET, up 0.82 percent on the NYSE.
Avantor (US05352A1007) scheduled its third-quarter 2026 results for October 28, 2026, while TD Cowen raised its target from USD 15.00 to USD 17.00 on October 13, 2026, according to Markets Insider. Avantor stock last traded at USD 17.29 on October 23, 2026 at 4:00 p.m. ET, up 0.82 percent on the NYSE.
October 28 earnings date
The company will release its third-quarter results before the NYSE opens on October 28, 2026, and will hold its conference call at 8:00 a.m. ET. Avantor published the date on October 1, 2026.
The scheduled report follows second-quarter revenue of USD 1.6923 billion, which increased 0.50 percent from the prior-year quarter. Adjusted earnings per share were USD 0.21, compared with a USD 0.19 consensus estimate, while GAAP diluted earnings per share were USD 0.06, according to Zacks on August 28, 2026.
The stock price position
On the NYSE, Avantor traded at USD 17.29 on October 23, 2026 at 4:00 p.m. ET. Its 52-week range was USD 7.26 to USD 17.45, placing the last price USD 0.16 below the high. Market capitalization was USD 11.7 billion and volume was 7,873,117 shares on that quote date.
Valuation and upcoming date
The finance data showed a negative trailing P/E of 20.60 on October 23, 2026, so the ratio does not provide a meaningful earnings comparison. Bernstein maintained a Hold rating and a USD 15.50 target on October 16, 2026, as reported by Markets Insider.
Comparison with peers
Avantor: up 0.82 percent, negative P/E 20.60, market capitalization USD 11.7 billion.
Thermo Fisher Scientific (NYSE, USD): down 0.40 percent, P/E 35.54, market capitalization USD 249.1 billion.
Danaher (NYSE, USD): up 0.33 percent, P/E 37.73, market capitalization USD 162.0 billion.
What the next report will test
The October 28 release will show whether the second-quarter revenue improvement translated into continued operating progress. Avantor's full-year 2026 adjusted earnings guidance stands at USD 0.80 to USD 0.83 per share, while the second-quarter adjusted earnings figure was USD 0.21 per share.
Avantor is a healthcare company in the medical instruments and supplies industry, serving life sciences and advanced technology customers. The company says its products and services support more than 300,000 customer locations in 180 countries.
Market context: Market report S&P 500.
